{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:01:54Z","timestamp":1781456514654,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.humimm.2025.111618","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T20:29:12Z","timestamp":1764707352000},"page":"111618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of PD-1 (rs36084323) gene polymorphism with autoimmune thyroid diseases"],"prefix":"10.1016","volume":"87","author":[{"given":"Nora M.","family":"Elkady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Elzeiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"Abd El-Raouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Elzeiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma.Z.","family":"El-Morsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin Z.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5009-4023","authenticated-orcid":false,"given":"Dalia Kamal","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humimm.2025.111618_b0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.humimm.2025.111618_b0010","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/a-0799-5068","article-title":"Autoimmune thyroid diseases","volume":"50","author":"Banga","year":"2018","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.humimm.2025.111618_b0015","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.12688\/f1000research.11535.1","article-title":"Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity","volume":"6","author":"Bliddal","year":"2017","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.humimm.2025.111618_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101388","article-title":"Graves\u2019 disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.humimm.2025.111618_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101367","article-title":"Hashimotos\u2019 thyroiditis: epidemiology, pathogenesis, clinic and therapy","volume":"33","author":"Ragusa","year":"2019","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.humimm.2025.111618_b0030","first-page":"203","article-title":"Hypothyroidism: etiology, diagnosis, and management","volume":"96","author":"Almandoz","year":"2012","journal-title":"Med. Clin."},{"issue":"1","key":"10.1016\/j.humimm.2025.111618_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101377","article-title":"Endocrine disruptors and thyroid autoimmunity","volume":"34","author":"Benvenga","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.humimm.2025.111618_b0040","unstructured":"L. Cui, X. Gu, H. Liu, H. Zheng, PD-1\/PD-L1 Expressions on Treg Cells in Patients with Autoimmune Thyroid Disease, (2021) [cited 2024 Aug 27]; Available from: https:\/\/scholar.archive.org\/work\/6etdo6wlqjb2vefzeb2lfwjqcu\/access\/wayback\/https:\/\/assets.researchsquare.com\/files\/rs-733027\/v1\/1f4fd181-ddd8-4fb7-86d9-093790f8292a.pdf?c=1629294516."},{"issue":"8","key":"10.1016\/j.humimm.2025.111618_b0045","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa053","article-title":"Emerging roles for noncoding RNAs in autoimmune thyroid disease","volume":"161","author":"Yin","year":"2020","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.humimm.2025.111618_b0050","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.7150\/ijbs.55381","article-title":"The emerging function and clinical significance of circRNAs in thyroid cancer and autoimmune thyroid diseases","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.humimm.2025.111618_b0055","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/cancers11081150","article-title":"Association between PD-1 and PD-L1 polymorphisms and the risk of cancer: a meta-analysis of case-control studies","volume":"11","author":"Hashemi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.humimm.2025.111618_b0060","doi-asserted-by":"crossref","unstructured":"M.E. Keir, M.J. Butte, G.J. Freeman, A.H. Sharpe. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol., 2008 Apr 23;26 (Volume 26, 2008):677\u2013704.","DOI":"10.1146\/annurev.immunol.26.021607.090331"},{"issue":"186","key":"10.1016\/j.humimm.2025.111618_b0065","article-title":"Progress in PD-1\/PD-L1 pathway inhibitors: from biomacromolecules to small molecules","volume":"15","author":"Lin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.humimm.2025.111618_b0070","unstructured":"M.R. Roshandel, H.M. Bakr, R. Lak, R.M.G. Taher, A. Barzinji, K.K. Salh, et al., Investigation of the effect of pd1. 1, pd1. 5, and pd1. 9 mutations on pd1 gene function with a system biology approach. Cent. Asian J. Med. Pharm. Sci. Innov., (2021);1(1):28\u201334."},{"issue":"310","key":"10.1016\/j.humimm.2025.111618_b0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","article-title":"PD-1\/PD-L and autoimmunity: a growing relationship","volume":"1","author":"Zamani","year":"2016","journal-title":"Cell. Immunol."},{"issue":"305","key":"10.1016\/j.humimm.2025.111618_b0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2017.02.006","article-title":"PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS","volume":"15","author":"Pawlak-Adamska","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"2\u20133","key":"10.1016\/j.humimm.2025.111618_b0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2007.02.006","article-title":"The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future","volume":"28","author":"Jacobson","year":"2007","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.humimm.2025.111618_b0090","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/jcm12062157","article-title":"Exploring the bio-functional effect of single nucleotide polymorphisms in the promoter region of the TNFSF4, CD28, and PDCD1 genes","volume":"12","author":"Chen","year":"2023","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.humimm.2025.111618_b0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/08916934.2021.1946796","article-title":"PD-1 gene polymorphisms and thyroid expression of PD-1 ligands differ between Graves\u2019 and Hashimoto\u2019s diseases","volume":"54","author":"Kawabata","year":"2021","journal-title":"Autoimmunity"},{"key":"10.1016\/j.humimm.2025.111618_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.013","article-title":"Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity","volume":"103","author":"Alvarez-Sierra","year":"2019","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.humimm.2025.111618_b0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12016-014-8451-x","article-title":"Gene therapy for autoimmune disease","volume":"49","author":"Shu","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.humimm.2025.111618_b0110","article-title":"Identification of multiple novel susceptibility genes associated with autoimmune thyroid disease","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2025.111618_b0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.humimm.2025.111618_b0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00439-009-0781-z","article-title":"PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis","volume":"127","author":"Ishizaki","year":"2010","journal-title":"Hum. Genet."},{"issue":"7","key":"10.1016\/j.humimm.2025.111618_b0125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s43018-020-0075-x","article-title":"PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer","volume":"1","author":"Oh","year":"2020","journal-title":"Nat Cancer."},{"key":"10.1016\/j.humimm.2025.111618_b0130","article-title":"Thyroid dysfunction (TD) induced by PD-1\/PD-L1 inhibitors in advanced lung cancer","author":"Wang","year":"2024","journal-title":"Heliyon [internet]."},{"issue":"3","key":"10.1016\/j.humimm.2025.111618_b0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3803\/EnM.2021.965","article-title":"Programmed cell death-ligand 1 (PD-L1) gene single nucleotide polymorphism in Graves\u2019 disease and Hashimoto\u2019s thyroiditis in Korean patients","volume":"36","author":"Yoon","year":"2021","journal-title":"Endocrinol. Metab."},{"issue":"35","key":"10.1016\/j.humimm.2025.111618_b0140","doi-asserted-by":"crossref","first-page":"e7805","DOI":"10.1097\/MD.0000000000007805","article-title":"Are programmed cell death 1 gene polymorphisms correlated with susceptibility to rheumatoid arthritis?: a meta-analysis","volume":"96","author":"Zou","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.humimm.2025.111618_b0145","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bjh.15085","article-title":"PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia","volume":"180","author":"Kasamatsu","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.humimm.2025.111618_b0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MPH.0000000000002909","article-title":"Relationship between cytotoxic T-lymphocyte-associated antigen-4: programmed death-1 genes polymorphisms and susceptibility to pediatric B-cell acute lymphoblastic leukemia","volume":"46","author":"Aref","year":"2024","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.humimm.2025.111618_b0155","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0190-9622(92)70068-Q","article-title":"Influence of gender on survival in patients with stage I malignant melanoma","volume":"26","author":"Vossaert","year":"1992","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925003891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925003891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:47:24Z","timestamp":1781455644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925003891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0198885925003891"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111618","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of PD-1 (rs36084323) gene polymorphism with autoimmune thyroid diseases","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111618"}}